<DOC>
	<DOCNO>NCT01909752</DOCNO>
	<brief_summary>This study test investigational vaccine , call DRibbles , treatment non-small cell lung cancer ( NSCLC ) . We hypothesize vaccination DRibble vaccine cause immune response protein contain DRibble vaccine protein antigens target strong immune response include common antigen share vaccine patient 's tumor .</brief_summary>
	<brief_title>Combination Vaccine Immunotherapy ( DRibbles ) Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer</brief_title>
	<detailed_description>This open-label , randomize study first 33 patient assign receive either : - DRibbles vaccine HPV vaccine - DRibbles vaccine , HPV vaccine , imiquimod - DRibbles vaccine , HPV vaccine , GM-CSF After 11 patient assign group , study arm great number vaccine-induced strong antibody response continue enrollment 15 patient . The primary objective determine best strategy induce strong ( &gt; 15 fold ) tumor-specific tumor-associated antibody responses patient stage III A B NSCLC . The goal select one regimen advance additional clinical trial .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Stage IIIA IIIB histologically proven nonsmall cell lung cancer Completion definitive therapy Enrollment 28 day 12 week completion definitive therapy Toxicities definitive therapy resolve less grade 1 ECOG performance status 01 Negative pregnancy test woman childbearing potential Agree avoid pregnancy father child study treatment Ability give inform consent comply protocol Anticipated survival minimum 6 month Prior therapy investigational agent must complete least 3 week prior study enrollment Normal organ marrow function define specific lab test Archived tumor tissue available Active autoimmune disease except vitilogo hypothyroidism Active malignancy Known HIV+ and/or Hepatitis B C positive Medical psychiatric condition would preclude safe participation Ongoing chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>DRibble Vaccine</keyword>
	<keyword>Imiquimod</keyword>
	<keyword>GM-CSF</keyword>
	<keyword>HPV vaccine ( Ceravix )</keyword>
	<keyword>Cyclophosphamide</keyword>
</DOC>